Company Newbury Pharmaceuticals AB

Equities

NEWBRY

SE0015244884

Drug Retailers

Market Closed - Nasdaq Stockholm 11:22:47 2024-06-07 am EDT 5-day change 1st Jan Change
3.22 SEK +9.52% Intraday chart for Newbury Pharmaceuticals AB +5.92% +4.89%

Business Summary

Newbury Pharmaceuticals AB is a Sweden-based pharmaceutical company for specialty prescription drugs. The Company’s existing portfolio is focused on the Scandinavian market and consists of pharmaceuticals from several therapeutic areas with oncology, rare diseases and neurology.

Number of employees: 5

Managers

Managers TitleAgeSince
Chief Executive Officer 53 20-12-31
Director of Finance/CFO 37 20-12-31
Director/Board Member - 22-07-31
Sales & Marketing 51 20-12-31

Members of the board

Members of the board TitleAgeSince
Founder 50 19-12-31
Director/Board Member 50 19-12-31
Director/Board Member 48 19-12-31
Director/Board Member 38 20-12-31
Director/Board Member - 22-07-31

Share class

VoteQuantityFree-FloatCompany-owned sharesTotal Float
Stock A 1 19,521,154 9,005,041 ( 46.13 %) 0 46.13 %

Shareholders

NameEquities%Valuation
9,905,924 40.83 % 3 M kr
Sumar Pharma Ltd.
12.73 %
3,087,308 12.73 % 959 165 kr
Pension Futur
4.164 %
1,010,050 4.164 % 313 802 kr
531,590 2.191 % 165 154 kr
393,082 1.620 % 122 123 kr
275,000 1.134 % 85 437 kr
Anil Okay
1.119 %
271,500 1.119 % 84 350 kr
Nordnet Pension Insurance
1.022 %
247,846 1.022 % 77 001 kr
Hexiron AB
0.9513 %
230,770 0.9513 % 71 696 kr
Gerhard Dal
0.9471 %
229,743 0.9471 % 71 377 kr

Company contact information

Newbury Pharmaceuticals AB

Medicon Village Scheeletorget 1

223 81, Lund

+46 46 12 11 20

http://www.newburypharma.com
address Newbury Pharmaceuticals AB(NEWBRY)
  1. Stock Market
  2. Equities
  3. NEWBRY Stock
  4. Company Newbury Pharmaceuticals AB